Goldman: Big Pharma Eyes China Biotech as Patent Cliff Nears
Goldman Sachs says big pharma is sourcing assets from China biotech as $440 billion in drug patents expire by 2032.
07/10/2026 02:329 min read
Goldman
Goldman Sachs: US Treasury selloff may be overdone, five factors cited
Goldman Sachs believes the recent US Treasury selloff may be overdone, citing five drivers, but says a rally may require lower energy prices or weaker…
07/10/2026 00:4213 min read
Goldman Sachs Names 5 Stocks to Buy Before Earnings Season
Goldman Sachs has buy ratings on five stocks before earnings season; four are down in 2026 while Baker Hughes has gained.
04/10/2026 04:4411 min read
Goldman now expects December Fed hike, sees chance of end to tightening
Goldman Sachs delayed its forecast for the next Fed rate hike to December from October after softer inflation and dovish Fed comments.
01/10/2026 22:5214 min read